(HELN) Helvetia Holding - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0466642201
HELN: Life, Non-Life, Reinsurance, Annuity, Pension, Insurance
Helvetia Holding AG is a Swiss-based insurance group with a rich history dating back to 1858. Headquartered in St. Gallen, Switzerland, the company operates across multiple European markets, including Germany, Austria, Spain, Italy, and France. Its business spans life insurance, non-life insurance, and reinsurance, making it a well-rounded player in the insurance sector. Helvetias diversified portfolio is designed to balance risk and return, catering to both individual and corporate clients.
In life insurance, Helvetia offers a range of products, including investment-linked policies, group life insurance, and annuity products. These solutions are tailored to meet the evolving financial security needs of its customers. On the non-life side, the company provides coverage for property, motor vehicles, health, accident, liability, and transport risks. This broad spectrum of offerings underscores Helvetias commitment to protecting its clients against various life and business uncertainties.
Helvetias reinsurance operations further complement its primary insurance business, allowing the company to manage its risk exposure effectively. This dual approach—combining direct insurance and reinsurance—positions Helvetia as a stable and resilient entity in the competitive European insurance landscape.
From a financial perspective, Helvetia Holding AG has a market capitalization of approximately 8.5 billion Swiss francs (CHF), reflecting its significant scale in the industry. With a price-to-earnings (P/E) ratio of 31.22, the company is valued at a premium, likely due to its strong market position and historical profitability. The price-to-book (P/B) ratio of 2.52 indicates that investors place a high value on the companys assets and future prospects. Meanwhile, the price-to-sales (P/S) ratio of 0.89 suggests a reasonable valuation relative to its revenue generation capabilities.
For investors and fund managers, Helvetia represents a compelling opportunity to gain exposure to a diversified, multinational insurance group with a long-standing history of operational excellence. Its balanced portfolio, robust financial metrics, and strategic market presence make it a standout player in the insurance industry.
Additional Sources for HELN Stock
HELN Stock Overview
Market Cap in USD | 10,462m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception |
HELN Stock Ratings
Growth 5y | 88.1% |
Fundamental | 42.5% |
Dividend | 66.8% |
Rel. Strength Industry | 18.2 |
Analysts | - |
Fair Price Momentum | 199.25 CHF |
Fair Price DCF | 396.49 CHF |
HELN Dividends
Dividend Yield 12m | 4.10% |
Yield on Cost 5y | 8.21% |
Annual Growth 5y | 4.73% |
Payout Consistency | 93.8% |
HELN Growth Ratios
Growth Correlation 3m | 94.5% |
Growth Correlation 12m | 95.4% |
Growth Correlation 5y | 94.5% |
CAGR 5y | 17.51% |
CAGR/Max DD 5y | 0.59 |
Sharpe Ratio 12m | 2.05 |
Alpha | 35.66 |
Beta | 0.26 |
Volatility | 17.99% |
Current Volume | 72.7k |
Average Volume 20d | 68.8k |
As of March 12, 2025, the stock is trading at CHF 172.30 with a total of 72,657 shares traded.
Over the past week, the price has changed by +1.17%, over one month by +6.49%, over three months by +13.80% and over the past year by +40.42%.
Partly, yes. Based on ValueRay Fundamental Analyses, Helvetia Holding (SW:HELN) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.45 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HELN as of March 2025 is 199.25. This means that HELN is currently undervalued and has a potential upside of +15.64% (Margin of Safety).
Helvetia Holding has no consensus analysts rating.
According to ValueRays Forecast Model, HELN Helvetia Holding will be worth about 215.2 in March 2026. The stock is currently trading at 172.30. This means that the stock has a potential upside of +24.89%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 151.4 | -12.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 215.2 | 24.9% |